Cases
Workhorse listing across all UPC cases. Filters apply across tabs.
| Case | Filed | Division | Category | Action | Claimant | Respondent | Status | Outcome | Decisions |
|---|---|---|---|---|---|---|---|---|---|
| UPC_CFI_2220/2025 | Dec 23, 2025 | Munich CD | Other | Generic | Amgen Inc. | Sanofi-Aventis Deutschland GmbH +2 | Written Phase | — | 0 |
| UPC_CoA_594/2025 | Jun 30, 2025 | Court of Appeal | Appeals | Appeal | — | — | Oral Phase | — | 0 |
| UPC_CoA_590/2025 | Jun 30, 2025 | Court of Appeal | Appeals | Appeal | — | — | Oral Phase | — | 0 |
| UPC_CoA_582/2025 | Jun 30, 2025 | Court of Appeal | Appeals | Appeal | — | — | Oral Phase | — | 0 |
| UPC_CoA_592/2025 | Jun 30, 2025 | Court of Appeal | Appeals | Appeal | — | — | Oral Phase | — | 0 |
| UPC_CoA_596/2025 | Jun 30, 2025 | Court of Appeal | Appeals | Appeal | — | — | Oral Phase | — | 0 |
| UPC_CoA_591/2025 | Jun 30, 2025 | Court of Appeal | Appeals | Appeal | — | — | Oral Phase | — | 0 |
| UPC_CoA_595/2025 | Jun 30, 2025 | Court of Appeal | Appeals | Appeal | — | — | Oral Phase | — | 0 |
| UPC_CoA_602/2025 | Jun 30, 2025 | Court of Appeal | Appeals | Appeal | — | — | Oral Phase | — | 0 |
| UPC_CoA_593/2025 | Jun 30, 2025 | Court of Appeal | Appeals | Appeal | — | — | Oral Phase | — | 0 |
| UPC_APP_3214/2025 | Jan 21, 2025 | Munich CD | Procedural & sub-applications | Generic | Name not displayed for GDPR reasons. Represented by Sture RYGAARD | Sanofi-Aventis Deutschland GmbH +3 | Written Phase | — | 0 |
| UPC_APP_47154/2024 | Aug 14, 2024 | Munich CD | Procedural & sub-applications | Generic | Dehns | Amgen Inc. | Written Phase | Procedural only | 1 |
| UPC_APP_47172/2024 | Aug 14, 2024 | Munich CD | Procedural & sub-applications | Generic | Dehns | Sanofi-Aventis Deutschland GmbH +1 | Written Phase | — | 0 |
| CC_586764/2023 | Nov 10, 2023 | Munich CD | Revocation | Counter claim for revocation | Regeneron Pharmaceuticals Inc. | Amgen Inc. | Case Closed | Revoked | 1 |
| UPC_APP_546231/2023 | Jul 11, 2023 | Munich CD | Procedural & sub-applications | Generic | Name not displayed for GDPR reasons. Represented by Oswin RIDDERBUSCH | Sanofi-Aventis Deutschland GmbH +1 | Written Phase | — | 0 |
| UPC_CFI_1/2023 | Jun 2, 2023 | Munich CD | Revocation | Revocation | Sanofi-Aventis Deutschland GmbH | Amgen Inc. | Case Closed | Revoked | 7 |